1
CB
CIO Bulletin Assistant
Online

Home Industry CBD Is Marijuana Rescheduling Head...

Is Marijuana Rescheduling Heading for a Court Clash Over State Cannabis Markets?


CBD

Marijuana Rescheduling Sparks Lawsuit

A second group of medical cannabis companies has taken the DEA to court, warning that new federal rules could shake state markets and leave patients paying the price.

Marijuana rescheduling was meant to bring relief, but it has now landed the federal government in court again. A second group of medical cannabis companies is suing the Drug Enforcement Administration, known as the DEA, over new rules that industry watchers fear could shake state-licensed markets.

What the Companies Are Fighting

Four medical cannabis companies in Pennsylvania filed the new case on Thursday. Each runs a full operation, from growing and processing to selling in its own shops. They asked a federal appeals court in Washington to pause the DEA rules, which say businesses must buy and sell only with firms that have federal registration or applied on time. The deadline is November 29.

The companies say the problem is confusion. They argue the DEA rolled out its registration forms in stages, leaving too little time to apply for their growing arms. If the rules stand, their own dispensaries could be barred from selling what their own growers produce. In their petition, the companies' lawyers warned, "A later victory would come too late." Could one deadline really shut down supply chains?

A Growing Legal Fight

This is not the first challenge. A day earlier, companies from Utah, Arizona and Oklahoma filed a separate suit, and the court has now combined the two cases. For CIO Bulletin readers following cannabis policy, the message is clear: marijuana rescheduling is facing real pushback.

Here is what else is stirring concern:

  • The DEA has refused registration to medical marijuana businesses in at least six states and Washington, DC.

  • The agency cites some state laws that allow non-medical sales or patient access without a doctor's written recommendation.

  • State regulators say they received little warning and almost no communication from the agency.

Gillian Schauer of the Cannabis Regulators Association has cautioned that some states may not have enough growers, makers and sellers left to keep supply chains alive, which could hurt patient access and state revenue. With the deadline days away, will the court step in?

News Source: Marijuana Moment, https://www.marijuanamoment.net/

Frequently Asked Questions

Everything you need to know about this news

Four Pennsylvania cannabis companies filed the newest case, following a separate suit from firms in Utah, Arizona and Oklahoma.

They are asking a federal appeals court to pause the DEA rules before the November 29 deadline arrives.

Businesses may only trade with federally registered firms or timely applicants, which could cut off supply chains and hurt patients who rely on medical marijuana.

Yes. It has refused registration to medical marijuana businesses in at least six states and Washington, DC.

The court has combined the two lawsuits and will weigh them together, while the November 29 deadline keeps getting closer.

Comments

Loading comments…
Loading comments…

Explore More

Recommended News

Latest  Magazines